Prollenium Medical Technologies Inc.
About Company
Prollenium Medical Technologies Inc. was founded in 2002 and is dedicated to the research, manufacturing, and commercialization of aesthetic medical products in the pharmaceutical and medical device industry. The company is committed to providing innovative products worldwide that are safe and viable. Flagship product lines include Revanesse® Versa™ and Revanesse® Lips™ Hyaluronic Acid Dermal Fillers. In 2016, the company opened its U.S. subsidiary for the commercialization of its best-in-class dermal filler range sold globally under the trade name Revanesse.
